|
Journal of Focused Ultrasound is a new channel for publishing and disseminating research
The Journal of Therapeutic Ultrasound (JTU) has launched its website and received its first manuscript for peer-review, marking the opening of an important new channel through which focused ultrasound researchers can publish their findings and make them quickly and broadly accessible to other stakeholders.
The new online, open access journal represents a collaboration of the Focused Ultrasound Foundation, the International Society for Therapeutic Ultrasound and the highly regarded internet publisher BioMed Central, Ltd. The JTU will cover all aspects of therapeutic focused ultrasound research and place special emphasis on translational and clinical studies.
Read e-Blast>
Interns complete Brain Program assignments during a very productive summer
 |
 |
|
Focused Ultrasound Foundation 2012 Summer Interns
(Left to right) Front row: Matthew Hantzmon, JT Booth and Graham Rolph; Back row: Yiqi Cao and Alisha Geldert
|
The Focused Ultrasound Foundation was proud to have five very bright and gifted undergraduate scientists-in-training tackle a variety of Brain Program projects as our first-ever summer interns.
"We established the internships to foster interest among the next generation of researchers in the development of focused ultrasound as a clinical tool and to address real-world challenges, the conquering of which could expedite adoption," explains Matt Eames, PhD, Director of Extramural Research. "We are all very impressed by what this group accomplished. Each project represents a valuable contribution to the field of focused ultrasound."
Intern roster
(Click on each name to learn about what each intern accomplished during the summer of 2012.)
Working on individual projects:
- Yiqi Cao, Biomedical Engineering major, University of Virginia, Class of 2015
Summer assignment: Investigate the potential of sonodynamic therapy
Potential impact: Sonodynamic therapy may expand the trans-cranial treatment envelope for FUS, allowing the treatment of more clinical indications.
- Matthew Hantzmon, Chemical Engineering major, Northwestern University, Class of 2015
Summer assignment: Find the most accurate calculation for lesion volume
Potential impact: Algorithm could help guide clinicians' selection of treatment parameters for clinical transcranial MR-guided focused ultrasound and save up to an hour in treatment time for brain cases (25% reduced treatment time).
- Graham Rolph, Aeronautical Engineering major, California Polytechnic State University, Class of 2016
Summer assignment: Install a Picture Archiving and Communications System; co-register MR and CT data with the National Cancer Institute
Potential impact: Publicly available datasets will allow researchers free access to valuable and rare clinical data for treatment simulations, which will help improve focused ultrasound technology.
Working on a collaborative assignment:
- Richard (JT) Booth, Computer Science/Engineering major, Harvey Mudd College, Class of 2015
Alisha Geldert, Biomedical Engineering major, University of Virginia, Class of 2015
Summer assignment: Develop an adaptive model to predict temperature elevation of brain tissue based on skull parameters
Potential impact: Technical analysis software will help provide a better understanding of treatment accuracy, which will lead to improved clinical treatments.
Jin Woo Chang, MD and Joseph Jankovic, MD join Movement Disorder Steering Committee
Two renown clinical experts have joined the Foundation’s Movement Disorders Steering Committee, the advisory group that is guiding focused ultrasound research related to Parkinson’s disease, essential tremor and other movement disorders.
|
 |
| Jin Woo Chang, MD, PhD |
Jin Woo Chang, MD, PhD of Yonsei University College of Medicine in Seoul, South Korea – One of the most distinguished and influential neuosurgeons in Korea and the Asia Pacific Region, Chang serves as professor and chairman of the Department of Neurosurgery and is director of the Brain Research Institute at Yonsei. He is president of several medical societies, including the Korean Society for Stereotactic and Functional Neurosurgery, the International Society of Reconstructive Neurosurgery and the Asian Australasian Society for Stereotactic and Functional Neurosurgery. He is also vice secretary and treasurer of the World Society for Stereotactic and Functional Neurosurgery.
Chang is currently serving as principal investigator of a pilot clinical trial using focused ultrasound to treat essential tremor.
Joseph Jankovic, MD of the Baylor College of Medicine in Houston, Texas – An internationally recognized movement disorders expert, Jankovic is a professor of Neurology and Distinguished Chair in Movement Disorders at Baylor. He is also the founder and director of the Parkinson's Disease Center and Movement Disorders Clinic and co-director of Parkinson's Disease Research Laboratory.
 |
|
| Joseph Jankovic, MD |
|
Jankovic has been the principal investigator of more than a hundred clinical trials, and his pioneering research on drugs for Parkinsonian disorders and hyperkinetic movement disorders has led to their approval by the U.S. Food and Drug Administration. He is a past president of the Movement Disorder Society, and an Honorary Member of the American Neurological Association.
In his advisory roles, Jankovic serves as a member of the executive scientific advisory board of The Michael J. Fox Foundation for Parkinson’s Research and the National Parkinson Foundation Clinical and Scientific Advisory Board. He has served on editorial boards of Neurology, Movement Disorders, Journal of Neurology Neurosurgery and Psychiatry, Acta Neurologica Scandinavica, Journal of Neurological Sciences, Neurology Medlink, Clinical Neuropharmacology, Neurotherapeutic, Expert Review of Neurotherapeutics, Journal of Parkinson’s Disease and other journals.
Other members of the Foundation’s Movement Disorders Steering Committee are: G. Frederick Wooten, Jr., MD of the University of Virginia (Chairman); Antonio DeSalles, MD, PhD of the University of California Los Angeles; W. Jeffrey Elias, MD of the University of Virginia; Andres Lozano, MD, PhD of the University of Toronto; and James C. Torner, PhD of the University of Iowa.
Jessica Foley and Emily McDuffie join Foundation team
|
 |
| Jessica Foley, PhD |
Jessica Foley, PhD, Scientific Director, is returning to the focused ultrasound community after completing a one-year American Association for the Advancement of Science (AAAS) Science and Technology Policy Fellowship at the National Science Foundation in Washington, DC. Prior to that, she spent three years working for InSightec as Neuro Projects Manager and Clinical Marketing Manager.
Foley's career in focused ultrasound began at the University of Washington where she completed her doctorate in bioengineering and wrote her dissertation on the biological effects of focused ultrasound on peripheral nerves. Her 11-year career in the field has spanned the academic, industrial and government worlds. Such breadth of experience gives a unique perspective and insight that will be critical to the Foundation, particularly in the areas of regulatory affairs and reimbursement.
 |
|
| Emily McDuffie |
|
As the Foundation's Scientific Director, Foley will cultivate relationships and strategic partnerships with governmental policy-makers and regulatory agencies, including the Food and Drug Administration, and with disease-specific foundations whose interests are similar to those of the Foundation. She will represent and advocate for the Foundation and the focused ultrasound community among a wide variety of stakeholders.
Emily McDuffie, Development Associate, is supporting the foundation's fundraising efforts and invitational events for donors. Prior to joining the Foundation, McDuffie spent six years in program management and development for Children, Incorporated, a non-profit child sponsorship organization. She is a 2006 graduate of Randolph-Macon College in Virginia.
Foundation Council welcomes Norwood and Marguerite Davis
|
 |
| Norwood and Marguerite Davis |
Norwood and Marguerite Davis of Richmond, Virginia, have joined the Foundation Council, a select group of advisors and advocates who work closely with the Board of Directors to advance the Foundation's mission. Welcoming them, Foundation Chairman Neal F. Kassell, MD said, "Norwood and Marguerite's interest in cancer research and leadership in the philanthropic community will be extremely beneficial to our work. In addition, Norwood's experience and knowledge of the insurance industry will provide insights and guidance with regards to the Foundation's reimbursement programs and initiatives."
Norwood Davis is the former Chairman and CEO of Trigon Healthcare and a former director of a number of public and privately held companies. He has held leadership positions with numerous nonprofit boards, including Hampden Sydney College, the Commonwealth Foundation for Cancer Research, Virginia Commonwealth University Health Services Foundation and Virginia Commonwealth University Massey Cancer Center. He is a graduate of Hampden Sydney College and the University of Virginia School of Law.
Marguerite Davis is owner of Davis, Uniquely Beautiful Jewelry, a fine jewelry boutique in Richmond, VA. She is currently in a leadership position on the Foundation Board for the Virginia Commonwealth University School of Engineering and has served on the Board of the Virginia Engineering Foundation at the University of Virginia and the Board of Trustees for Hampden Sydney College. She is a graduate of the University of Virginia and the Gemological Institute of America.
TRAIN inventory lists Foundation among organizations with a venture philanthropy focus
FasterCures has announced the availability of its new The Research Acceleration and Innovation Network (TRAIN) Inventory. The inventory, which lists the Focused Ultrasound Foundation, catalogues the operational and partnering practices of nonprofit disease research foundations, particularly those with a venture philanthropy focus. FasterCures says the inventory is designed to help potential collaborators better understand the landscape of disease research foundations and engage in meaningful partnerships with them.
View inventory >
|
